Blog

Blog

MORE +
scroll down

News Center

Group Announcement

11-05

Great News!!! Several subsidiaries of Xuanyu Pharmaceutical Group have successfully passed the ISO9001 quality system certification and the U.S. FDA certification.

Several subsidiaries of Xuanyu Pharmaceutical Group have successfully passed ISO9001 quality system certification and U.S. FDA certification.

Great News!!! Several subsidiaries of Xuanyu Pharmaceutical Group have successfully passed the ISO9001 quality system certification and the U.S. FDA certification.

09-06

The 62nd China (Guangzhou) International Beauty Expo concluded successfully from September 4 to 6, 2023.

The 62nd China (Guangzhou) International Beauty Expo concluded successfully from September 4 to 6, 2023! Xuanyu Pharmaceutical Group was invited to participate in this grand event as an exhibitor.

The 62nd China (Guangzhou) International Beauty Expo concluded successfully from September 4 to 6, 2023.

12-20

Urbanization unleashes grassroots demand, presenting opportunities for the medical device sector.

Although the “strong start” that many investors had been anticipating for the Year of the Snake did not materialize, the market’s pullback couldn’t stem the remarkable surge in the pharmaceutical sector.

Urbanization unleashes grassroots demand, presenting opportunities for the medical device sector.

12-20

Focus on institutional development and improve the regulatory framework for medical devices.

The SFDA has actively promoted the revision of the "Regulations on the Supervision and Administration of Medical Devices," organizing and participating in numerous special meetings.

Focus on institutional development and improve the regulatory framework for medical devices.

12-20

The Ministry of Health and five other departments jointly issued the "Guidelines for Centralized Procurement of High-Value Medical Consumables (Trial)."

Procurement of high-value medical consumables across various regions suffers from issues such as low concentration, high procurement prices

The Ministry of Health and five other departments jointly issued the "Guidelines for Centralized Procurement of High-Value Medical Consumables (Trial)."

12-20

Centralized procurement takes off—high-value medical devices may soon carry low-price labels.

In accordance with the requirements of six departments, including the Ministry of Health, high-value medical consumables such as vascular intervention devices

Centralized procurement takes off—high-value medical devices may soon carry low-price labels.

12-20

Enforcement Q&A on Medical Device Manufacturing Addresses

In the registration management of medical devices, the manufacturing address is more critical than the registration address. According to the relevant provisions of the "Measures for the Registration and Administration of Medical Devices"

Enforcement Q&A on Medical Device Manufacturing Addresses

12-20

Last year, China’s trade deficit in vascular stents was significant.

There are a total of 53 companies in China engaged in the import of vascular stents, including 17 foreign-invested enterprises with an import value of US$248 million

Last year, China’s trade deficit in vascular stents was significant.

12-20

The new method can control stem cell differentiation on demand.

Stem cells are highly versatile, and scientists have long been puzzled about which organs or tissues they will ultimately become. According to a report by the American Physical Society’s website on August 28

The new method can control stem cell differentiation on demand.

12-20

Biopharmaceutical planning is coming your way.

With news that the 12th Five-Year Plan for the pharmaceutical industry is about to be released, the biopharmaceutical sector has shown exceptionally strong performance

Biopharmaceutical planning is coming your way.

12-20

Bacterial antibiotic resistance has long had genetic origins.

Antibiotics have been used as medications for less than a century, yet today, superbugs with antibiotic resistance are causing headaches for the medical community.

Bacterial antibiotic resistance has long had genetic origins.

12-20

China’s biopharmaceutical market is set to reach 800 billion yuan, with strong demand for new vaccines.

Fu Mingzhong, Executive President of the China Pharmaceutical Commerce Association, recently predicted at the 69th China Pharmaceutical Fair that the biopharmaceutical

China’s biopharmaceutical market is set to reach 800 billion yuan, with strong demand for new vaccines.
< 1 >

Xi'an Xuanyu Pharmaceutical Group

Nationwide Unified Customer Service:

+864000570159

Contact phone number:+86 29-89864608

Company email:463879555@qq.com

Address: Room 10402, Unit 1, Building 2, Science and Technology Enterprise Accelerator, No. 6 West Qinling Avenue, Caotang Science and Technology Industrial Base, High-tech Zone, Xi'an City, Shaanxi Province

Official Account

Official Account

Mobile site

Mobile site

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Copyright © 2026 Xi'an Xuanyu Pharmaceutical Group

Powered by www.300.cn

SAF Coolest v1.2 设置面板QVPSF-ZMFA-YSSFE-ZWA

图片ALT信息： Xi'an Xuanyu Pharmaceutical Group
违禁词： First, top-notch, first-class, leading, unique, king, leader, pioneer, ultimate,
营业执照及SEO链接： Business license

无数据提示

Sorry, there is currently no content in this section.!

You can view other sections or return.Home

SVG图标库请自行添加图标，用div包起来，并命名使用